Milestone Furniture delays FY26 results submission
Milestone Furniture Limited has reported a delay in submitting its audited financial results for the quarter and financial year ended March 31, 2026, due to the medical emergency of a key director. The company is currently unable to finalize the results and obtain necessary approvals but is working to complete the process. Milestone Furniture will update BSE Limited once the situation normalizes.

*this image is generated using AI for illustrative purposes only.
Milestone Furniture Limited has announced a delay in the submission of its audited financial results for the quarter and financial year ended March 31, 2026. The company cited unforeseen circumstances arising from the serious health condition of a key director, who suffered a brain hemorrhage and is currently undergoing medical treatment, as the reason for the postponement. This situation has prevented the company from completing necessary processes and obtaining required approvals within the prescribed timeline.
The disclosure was made to BSE Limited pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Milestone Furniture stated that it is making all possible efforts to complete the pending formalities and finalize the audited results at the earliest. The company committed to keeping the stock exchange informed of further developments and submitting the results as soon as the situation normalizes.
| Detail | Information |
|---|---|
| Company | Milestone Furniture Limited |
| Scrip Code | 541337 |
| Reporting Period | Quarter and Financial Year Ended March 31, 2026 |
| Reason for Delay | Medical emergency of a key director |
| Regulatory Reference | Regulation 30 and 33 of SEBI LODR, 2015 |
| Filing Date | June 24, 2026 |
Historical Stock Returns for Milestone Furniture
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +4.30% | +8.53% | -5.08% | +299.72% | -0.42% |
What is the revised timeline for the submission of the audited financial results?
How will the absence of the key director impact the company's operational decision-making in the interim?
Are there contingency plans in place to delegate the director's responsibilities to ensure business continuity?






























